Navigation Links
Knome Announces KnomeDISCOVERY Research Awards Program
Date:4/28/2010

CAMBRIDGE, Mass., April 28 /PRNewswire/ -- Knome today announced the launch of its KnomeDISCOVERY Research Awards Program.  Given annually, the awards will fund innovative research projects that help reveal the genetic underpinnings of diseases and other important human traits. To inaugurate the program, Knome will award its exome sequencing and interpretation services to three winning research groups, each of which will study a pair of human exomes in order to answer a compelling biological question.  

Founded by Harvard geneticist George Church and led by internationally recognized scientists, clinicians, and bioinformaticians, Knome provides cutting-edge genome sequencing and interpretation services for biomedical researchers and families seeking to understand the causes of human disease.

"Genome sequence analysis is revolutionizing biomedical research.  My hope is that these awards will ignite researchers' imaginations," said George Church, Ph.D., Co-Founder & Chief Scientific Advisor of Knome. "Many experts in human disease stand to gain remarkable insights from exome sequencing, but could use guidance in interpreting the vast amount of data involved. Knome's sequence interpretation services can help such scientists play driving roles in the genomic revolution."

The company invites researchers to submit proposals before June 15, 2010; winners will be announced on July 30, 2010.  A panel of scientific advisors, led by George Church, will judge proposals on scientific merit, feasibility, and funding need.  Please see www.knome.com/awards for more information.

About Knome

Human genomics for disease investigation

Based in Cambridge, Mass., Knome is a leading human genomics company focused on providing secure, state-of-the-art sequencing and analysis solutions for biomedical researchers and motivated families that seek to understand the genetic underpinnings of disease. Led by internationally recognized geneticists, clinicians, and bioinformaticians, Knome is responsible for sequencing and interpreting more genomes than any other company in the world. Knome is a privately held company. For more information, please visit www.knome.com.


'/>"/>
SOURCE Knome
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Knome Featured in New PBS Series Faces of America with Henry Louis Gates, Jr.
2. Knome Launches First Platform-Agnostic Human Genome Sequencing and Analysis Service for Researchers
3. Scripps Announces Sale of United Medias Licensing Business for $175 Million
4. YM BioSciences announces controlled equity offering
5. MedQuist Announces Completion of Spheris Transaction
6. BIO-IT World Announces the Winners of its 2010 Best Practices Awards Program
7. Facet Solutions Announces 2 Year Data from US Pilot Study
8. Moffitt Cancer Center Announces Growing Interest in Recently Launched Prognostic Test for Non-Small Cell Lung Cancer
9. Healthcare Data Solutions Announces Latest Database, PrescriberPRO@Home.
10. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2010 Financial Results
11. Gramene Announces Scholarships for Groups Underrepresented in Science to Learn How to Use Bioinformatics and Genomics Resources
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ON , June 27, 2016 /PRNewswire/ - BIOREM Inc. ... has been advised by its major shareholders, Clean Technology ... United States based venture capital ... shares of Biorem (on a fully diluted, as converted ... the disposition of their entire equity holdings in Biorem ...
(Date:6/27/2016)... ... June 27, 2016 , ... Rolf K. Hoffmann, ... faculty of the University of North Carolina Kenan-Flagler Business School effective ... at UNC Kenan-Flagler, with a focus on the school’s international efforts, leading classes ...
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of ... higher end machines that use the more unconventional z-dimension of 20mm. Z-dimension ... of the cuvette holder. , FireflySci has developed several Agilent flow cell product ...
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
Breaking Biology Technology:
(Date:6/3/2016)... 2016 Das DOTM ... Nepal hat ein 44 Millionen ... Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an ... und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale ... teilgenommen, aber Decatur wurde als konformste und ...
(Date:6/1/2016)... , June 1, 2016 Favorable ... Election Administration and Criminal Identification to Boost Global Biometrics ... recently released TechSci Research report, " Global Biometrics Market ... Competition Forecast and Opportunities, 2011 - 2021", the global ... by 2021, on account of growing security concerns across ...
(Date:5/12/2016)... 12, 2016 WearablesResearch.com , a brand ... overview results from the Q1 wave of its quarterly ... was consumers, receptivity to a program where they would ... health insurance company. "We were surprised to ... Michael LaColla , CEO of Troubadour Research, "primarily ...
Breaking Biology News(10 mins):